Redeye leaves a short comment on the exclusive option and license agreement between AC Immune and Takeda for the Alzheimer’s disease vaccine candidate ACI-24.060.
ANNONS
Redeye leaves a short comment on the exclusive option and license agreement between AC Immune and Takeda for the Alzheimer’s disease vaccine candidate ACI-24.060.